ESC Professional Premium Access

Low dose rivaroxaban therapy in aspirin allergic patients undergoing percutaneous coronary intervention

Congress Presentation

About the speaker

Doctor Simon Manjooran

Barts Heart Centre, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

6 more presentations in this session

Effect of exercise-based cardiac rehabilitation on the ischemic threshold in patients with high-risk ischemic heart disease

Speaker: Doctor J. Lara Vargas (Mexico City, MX)

Thumbnail

Impact of different antiplatelet therapy cessation modes on outcomes in patients treated with ticagrelor with or without aspirin after PCI: the twilight-antiplatelet cessation study

Speaker: Doctor A. Spirito (New York, US)

Thumbnail

Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis of cohort studies

Speaker: Mr S. Soulaidopoulos (Athens, GR)

Thumbnail

Lipoprotein(a), cardiovascular events, and benefit of P2Y12 inhibition: insights from the PEGASUS-TIMI 54 trial

Speaker: Doctor S. Patel (Boston, US)

Thumbnail

Thrombin generation and endothelial progenitor cell function among patients with acute myocardial infarction treated with prasugrel versus ticagrelor

Speaker: Doctor M. Wiessman (Petah Tikva, IL)

Thumbnail

Access the full session

Coronary artery disease - Pharmacotherapy 3

Speakers: Doctor S. Manjooran, Doctor J. Lara Vargas, Doctor A. Spirito, Mr S. Soulaidopoulos, Doctor S. Patel...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations